The StarClose Vascular Closure Device in Antegrade and Retrograde Punctures: A Single-Center Experience
- Resource Type
- Authors
- Sanjay Nadkarni; Jonathan Tibballs; Simon Richard Coles; Albert Ho Yuen Chiu
- Source
- Journal of Endovascular Therapy. 17:46-50
- Subject
- Male
medicine.medical_specialty
Time Factors
Hemorrhage
Punctures
Femoral artery
Single Center
medicine.artery
Catheterization, Peripheral
medicine
Humans
Radiology, Nuclear Medicine and imaging
Vascular closure device
Major complication
Aged
Retrospective Studies
Aged, 80 and over
Retrospective review
Hemostatic Techniques
business.industry
Mean age
Equipment Design
Middle Aged
Surgery
Treatment Outcome
Female
Cardiology and Cardiovascular Medicine
Complication
business
- Language
- ISSN
- 1545-1550
1526-6028
To evaluate the StarClose device and compare its success rates in antegrade and retrograde puncture closures.A retrospective review of all StarClose deployments from April 2005 to July 2007 was performed in a single tertiary referral institution radiology department. In this time period, 143 StarClose devices were deployed in 132 patients (102 men; mean age 68+/-14 years). Of these, 40 (28%) were deployed after antegrade and 103 (72%) after retrograde common femoral arterial punctures. Hospital notes were reviewed to evaluate minor (managed conservatively with compression) and major (requiring surgical intervention) complication rates in the immediate postprocedure period and the following 24 hours. Late complications were also assessed.There were 11 (7.7%) immediate failures of device deployment: 4/40 (10.0%) antegrade and 7/103 (6.8%) retrograde. Within these 11 punctures, 1 major complication occurred that required surgical retrieval of the device following a retrograde puncture. No other major and 12 (9.1%) minor complications occurred following the 132 successful StarClose deployments. No late complications were seen on clinical or radiological follow-up. The total major complication rate was 0.7% (1/143). The total minor complication rate was 15.4% (22/143): 9/40 (22.5%) following antegrade punctures and 13/103 (12.6%) following retrograde punctures.The StarClose device is associated with a low major complication rate. A higher rate of minor complications was observed following antegrade punctures but all were managed with simple compression. Prospective randomized trials comparing closure devices are needed to evaluate their relative efficacy and safety in antegrade and retrograde punctures.